Epithelial ovarian cancers (advanced stage)SpanoJ.-P.LucchiE.SezeurA.LhommeC.ingentaconnectBulletin Du Cancer
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many cancer cells as possible. Indeed, the three phases...
stage ovarian cancer: 1) referral to an expert center, with a rate of optimal primary cytoreduction of 75% and utilization of combined intraperitoneal and intravenous adjuvant chemotherapy, and 2) referral to a less experienced center, with a rate of optimal primary cytoreduction of 25% and ...
Currently, women are surviving longer with advanced ovarian cancer and treatment aims to improve quality of life along with increasing survival.doi:10.1007/978-1-4614-8271-0_10Butler, JohnLawrence, AlexandraSpringer USButler, J. & Lawrence, A. (2014). Treatment of advanced stage ovarian cancer....
There is a dramatic revolution under way in the treatment of advanced-stage prostate cancer, which for many years consisted of systemic chemotherapy that offered only palliation of symptoms and no hope of improved survival. The last decade has witnessed the debut of a completely new arsenal of ...
Compared to non-Hispanic white women, non-Hispanic black women were 1.22 (95% CI: 1.04-1.43) times more likely to have advanced stage diagnosis (p=0.015) and were 62% (95% CI: 0.31-0.47) less likely to receive surgery (pConclusion: While racial/ethnic disparity in ovarian cancer ...
aOvarian cancer has one of the highest mortality rates of all gynecologic malignant tumors. More than 70% of patients are late-stage at diagnosis [1], and the 5-year survival rate is approximately 19~40% [2-3]. Locoregional recurrence and distant metastases are ominous events in patients wi...
Objective To evaluate the oncologic safety and reproductive outcomes in patients with advanced-stage borderline ovarian tumors (BOTs). Study design The medical records of patients with advanced-stage BOTs who were treated between 1997 and 2009 were reviewed retrospectively. Reproductive outcomes were asses...
Aim: Report the case of a patient with an International Federation of Gynecology and Obstetrics Stage IIIc malignant ovarian germ cell tumor, who had conservative surgery and chemotherapy with a good fertility outcome. A 23-year-old North African woman with a left malignant ovarian germ cell ...
ObjectiveThe aim of this review is to report our experience and the feasibility of neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer.MethodsForty-five patients with primarily unresectable advanced-stage epithelial ovarian cancer were treated in our center between 1995 and 2002 by pl...